# TWILIGHT BIOSCIENCE, INC.: A HERV-K (HML-2) Immunization Strategy for the Treatment and Prevention of Amyotrophic Lateral Sclerosis

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | TWILIGHT BIOSCIENCE, INC. |
| Location | TOPSFIELD, MA |
| Project | A HERV-K (HML-2) Immunization Strategy for the Treatment and Prevention of Amyotrophic Lateral Sclerosis |
| Project number | 1U44NS149352-01 |
| Mechanism | U44 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $497,416 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-22 to 2027-08-31 |
| UEI | YTMPKL72Y4H7 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11373396). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.